What Splash SBEVs 740 Decline Means for Investors 20260519 FIGS FIGS Stock Slides 159 Support at 1119 20260515 Incannex Healthcare IXHL Stock Slides 429 Support at 360 20260518 Chinese EVs Surge Globally but Remain Stalled in US Market SpaceXs IPO Filing Hints at Asteroid Mining Ambitions and Potential Billionaire Windfalls Tilray Brands TLRY Q1 2026 Earnings Miss Breaking Down the Numbers CNTA Q1 2026 Earnings Steady Execution Amidst a TopLine Miss Rising Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Reveals Ryanair Holdings RYAAY Posts Record 226 Billion Profit for Fiscal Year 2026 Up 40 Cleaning Product Misuse Surfaces That May Not Be Suitable for Windex and Potential Brand Impact CoreWeave Stock Cautious Outlook Amid AI Infrastructure Boom Iran Publishes Map Asserting Control Over Strait of Hormuz Raising Geopolitical Tensions Bloom Energy Surges 12 on 26 Billion AI Data Center Fuel Cell Deal with Nebius Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing Personalis Q1 2026 Earnings EPS Misses Estimates as Stock Gains Amid Sparse Financial Disclosure DBI Q1 2026 Earnings Narrower Loss Beats Estimates Shares Rally Over 6 EHAB Q4 2025 Earnings EPS Misses Estimates Amid Operational Headwinds NATR Q1 2026 Earnings Strong EPS Beat Drives Profitability Focus Amid Modest Market Response BRFH Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Progress Spectral AI Inc MDAI Q1 2026 Earnings WiderThanExpected Loss Amid Absent Revenue Disclosure LGL Q1 2026 Earnings Sharp EPS Miss Amidst Minimal Revenue Disclosure Unifi Inc UFI Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Edges Higher STWD Q1 2026 Earnings EPS Misses Estimates as Real Estate Challenges Persist DNOW Q1 2026 Earnings EPS Misses Estimates by 8775 Shares Decline CSIQ Q1 2026 Earnings NarrowerThanExpected Loss Shows Cost Discipline Amid Solar Market Challenges Oura Health Files Confidentially for IPO Signaling Potential Public Market Debut NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus